Scorpius Holdings has been selected to join the Medical CBRN Defense Consortium, a key organization advancing the development of medical countermeasures and related technologies to protect U.S. military personnel and civilians from chemical, biological, radiological, and nuclear threats. The MCDC, established in 2015 under the U.S. Department of Defense, serves as a collaborative framework for government, industry, and academia to partner on cutting-edge medical solutions. Its mission is to rapidly advance research, development, and manufacturing of technologies that safeguard national security. As a member, Scorpius will contribute its proprietary scientific expertise and resources to accelerate innovations aimed at addressing CBRN threats. Membership in the consortium allows Scorpius to engage with government stakeholders, collaborate with other innovative companies and academic institutions, and pursue funding opportunities for projects aligned with the DoD’s medical CBRN defense priorities.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCPX:
- Scorpius signs contract to provide bioanalytical services to biotech company
- Scorpius Holdings initiated with a Buy at ThinkEquity
- Scorpius Holdings commends passage of the BIOSECURE Act
- Scorpius Holdings selected for RRPV to accelerate countermeasure development
- Scorpius Holdings releases letter to shareholders from CEO
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue